Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > TLD-1433 kills various viruses within seconds

<< Previous

Bullboard Posts

Next >>

Post by ScienceFirston Jul 11, 2022 10:24pm

309 Views

Post# 34816966

TLD-1433 kills various viruses within seconds

A refresher ... on how potent and intended for which usage and also what subset of patients:

Theralase compound can kill influenza virus, Zika virus and human coronaviruses within seconds.

Thus, the compound may represent a very rapid and very safe alternative to standard methods that are used to prepare inactivated virus vaccines, and may also be useful as a therapeutic for individuals who cannot receive normal vaccines.